SYNTHROIDHCPPR.COM: Keyword Density Checker

Total words: 3685 | 2-word phrases: 990 | 3-word phrases: 1092 | 4-word phrases: 1122

PAGE INFO

Title	Try to keep the title under 60 characters (4 characters) Home
Description	Try to keep the meta description between 50 - 160 characters (177 characters) Learn about keeping thyroid levels in line with SYNTHROID® (levothyroxine sodium tablets), a once daily thyroid hormone replacement therapy for the treatment of hypothyroidism.
Keywords	Meta keywords are not recommended anymore (177 characters) Hypothyroidism
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	used for the	10	0.92%
2	in patients with	8	0.73%
3	should not be	8	0.73%
4	pituitary and tertiary	6	0.55%
5	for oral use	6	0.55%
6	weight loss in	6	0.55%
7	euthyroid patients doses	6	0.55%
8	patients doses within	6	0.55%
9	doses within the	6	0.55%
10	and tertiary hypothalamic	6	0.55%
11	of daily hormonal	6	0.55%
12	obesity or for	6	0.55%
13	in primary thyroidal	6	0.55%
14	therapy in primary	6	0.55%
15	replacement therapy in	6	0.55%
16	a replacement therapy	6	0.55%
17	as a replacement	6	0.55%
18	range of daily	6	0.55%
19	sodium tablets for	6	0.55%
20	requirements are ineffective	6	0.55%
21	are ineffective for	6	0.55%
22	or for weight	6	0.55%
23	for weight loss	6	0.55%
24	tablets for oral	6	0.55%
25	alone or with	6	0.55%
26	synthroid should be	6	0.55%
27	important safety information	6	0.55%
28	including synthroid either	6	0.55%
29	synthroid either alone	6	0.55%
30	either alone or	6	0.55%

#	Keyword	Frequency	Density
1	requirements are ineffective for	6	0.53%
2	tablets for oral use	6	0.53%
3	range of daily hormonal	6	0.53%
4	patients doses within the	6	0.53%
5	euthyroid patients doses within	6	0.53%
6	for weight loss in	6	0.53%
7	or for weight loss	6	0.53%
8	obesity or for weight	6	0.53%
9	for the treatment of	6	0.53%
10	be used for the	6	0.53%
11	not be used for	6	0.53%
12	should not be used	6	0.53%
13	either alone or with	6	0.53%
14	synthroid either alone or	6	0.53%
15	including synthroid either alone	6	0.53%
16	sodium tablets for oral	6	0.53%
17	used for the treatment	6	0.53%
18	therapy in primary thyroidal	6	0.53%
19	levothyroxine sodium tablets for	6	0.53%
20	as a replacement therapy	6	0.53%
21	pituitary and tertiary hypothalamic	6	0.53%
22	a replacement therapy in	6	0.53%
23	replacement therapy in primary	6	0.53%
24	or even lifethreatening manifestations	4	0.36%
25	ineffective for weight reduction	4	0.36%
26	for weight reduction larger	4	0.36%
27	weight reduction larger doses	4	0.36%
28	reduction larger doses may	4	0.36%
29	produce serious or even	4	0.36%
30	serious or even lifethreatening	4	0.36%
31	indicated in adult and	4	0.36%
32	even lifethreatening manifestations of	4	0.36%
33	lifethreatening manifestations of toxicity	4	0.36%
34	synthroid is not indicated	4	0.36%
35	particularly when given in	4	0.36%
36	when given in association	4	0.36%
37	given in association with	4	0.36%
38	in association with sympathomimetic	4	0.36%
39	association with sympathomimetic amines	4	0.36%
40	such as those used	4	0.36%

#	URL	Whois	Check
1	https://www.rxabbvie.com/pdf/synthroid.pdf	Whois	rxabbvie.com
2	https://www.rxabbvie.com/pdf/synthroid.pdf	Whois	rxabbvie.com
3	https://www.rxabbvie.com/pdf/synthroid.pdf	Whois	rxabbvie.com
4	https://www.abbvie.com/accessibility-statement.html	Whois	abbvie.com
5	https://www.abbvie.com/contactus.html	Whois	abbvie.com
6	https://www.abbvie.com/termsofuse.html	Whois	abbvie.com
7	https://privacy.abbvie/privacy-policies/us-privacy-policy.html	Whois	privacy.abbvie
8	https://abbviemetadata.my.site.com/AbbvieDSRM	Whois	site.com
9	https://www.abbvie.com/	Whois	abbvie.com
10	https://www.abbviemedinfo.com	Whois	abbviemedinfo.com